Pier-Luigi Lollini
Università degli Studi di Bologna
H-index: 67
Europe-Italy
Top articles of Pier-Luigi Lollini
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
IL-1 Family Members in Bone Sarcomas | Lorena Landuzzi Francesca Ruzzi Evelin Pellegrini Pier-Luigi Lollini Katia Scotlandi | 2024/1/25 | |
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9), through an innovative virus-like particles (VLP)-based vaccine, enhance the antitumoral activity of a HER-2-VLP … | European Journal of Cancer | F Ruzzi L Scalambra MS Semprini OM Pittino C Cappello | 2024/3/1 |
Engagement of CD99 activates distinct programs in Ewing sarcoma and macrophages | Cancer Immunology Research | Maria Cristina Manara Cristina Manferdini Camilla Cristalli Marianna Carrabotta Spartaco Santi | 2024/2/2 |
Preclinical activity of ES2B-C001, a human candidate HER-2 virus-like particle (VLP) vaccine, against mammary carcinoma onset and metastasis | Cancer Research | Francesca Ruzzi Arianna Palladini Stine Clemmensen Annette Strobaek Nicolaas Buijs | 2023/4/4 |
Synovial sarcoma preclinical modeling: Integrating transgenic mouse models and patient-derived models for translational research | Lorena Landuzzi Francesca Ruzzi Pier-Luigi Lollini Katia Scotlandi | 2023/1/18 | |
IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience | BMC cancer | Elisabetta Setola Stefania Benini Alberto Righi Gabriella Gamberi Elisa Carretta | 2023/9/26 |
Mechanisms of resistance to last generation EGFR Inhibitors: hijacking NRG1/ERBB3 axis. | Italian Journal of Anatomy and Embryology | Alessandra Morsell Donatella Rqmaniello Chiara Miroglio Cinzia Girone Michela Sgarzi | 2023/9/11 |
Virus-like particle (VLP) vaccines for cancer immunotherapy | Francesca Ruzzi Maria Sofia Semprini Laura Scalambra Arianna Palladini Stefania Angelicola | 2023/8/19 | |
Innovative breakthroughs for the treatment of advanced and metastatic synovial sarcoma | Lorena Landuzzi Maria Cristina Manara Laura Pazzaglia Pier-Luigi Lollini Katia Scotlandi | 2023/7/30 | |
Targeting CD99 compromises the oncogenic effects of the Chimera EWS–FLI1 by inducing reexpression of Zyxin and inhibition of GLI1 activity | Molecular Cancer Therapeutics | Tommaso Balestra Maria Cristina Manara Maria Antonella Laginestra Michela Pasello Alessandra De Feo | 2022/1/1 |
CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality | Journal of Hematology & Oncology | Carlo Sorrentino Luigi D’Antonio Stefania Livia Ciummo Cristiano Fieni Lorena Landuzzi | 2022/10/13 |
Divergent transcriptional and transforming properties of PAX3-FOXO1 and PAX7-FOXO1 paralogs | PLoS Genetics | Line Manceau Julien Richard Albert Pier-Luigi Lollini Maxim VC Greenberg Pascale Gilardi-Hebenstreit | 2022/5/23 |
Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma | Cell Death & Disease | Francesca Chiarini Francesca Paganelli Tommaso Balestra Cristina Capanni Antonietta Fazio | 2022/4/14 |
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis | Cellular Oncology | Michela Pasello Anna Maria Giudice Camilla Cristalli Maria Cristina Manara Caterina Mancarella | 2022/12 |
Integrated molecular characterization of patient-derived models reveals therapeutic strategies for treating CIC-DUX4 sarcoma | Cancer research | Marianna Carrabotta Maria Antonella Laginestra Giorgio Durante Caterina Mancarella Lorena Landuzzi | 2022/2/15 |
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug … | Translational Lung Cancer Research | Francesca Ruzzi Stefania Angelicola Lorena Landuzzi Elena Nironi Maria Sofia Semprini | 2022/11 |
Nuclear shape instability evoked by lamin A deregulation promotes metastases in Ewing sarcoma | Italian Journal of Anatomy and Embryology | Francesca Paaanelli Tommaso Balestra Cristina Capanni Antonietta Fazio Pol Arnau Romero | 2022 |
Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine | Biomedicines | Francesca Ruzzi Arianna Palladini Stine Clemmensen Anette Strøbæk Nicolaas Buijs | 2022/10/20 |
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression | Oncogenesis | Veronica Giusti Francesca Ruzzi Lorena Landuzzi Marianna L Ianzano Roberta Laranga | 2021/11/13 |
HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy | Carla De Giovanni Lorena Landuzzi Arianna Palladini Giordano Nicoletti Patrizia Nanni | 2021/7/16 |
Co-Authors
